Genfit SA [NASDAQ: GNFT] closed the trading session at $6.06 on 02/10/21. The day’s price range saw the stock hit a low of $5.67, while the highest price level was $7.19. The company report on February 11, 2021 that GENFIT: 2021 Financial Calendar.
Lille, France; Cambridge, MA; February 10, 2021 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and liver diseases, announced its provisional financial calendar for 2021.
February 26, 2021: Publication of revenue and cash position at December 31, 2020.
The stocks have a year to date performance of 26.25 percent and weekly performance of 16.54 percent. The stock has been moved at 18.13 percent over the last six months. The stock has performed 14.12 percent around the most recent 30 days and changed 48.89 percent over the most recent 3-months.
If compared to the average trading volume of 104.85K shares, GNFT reached to a volume of 8429794 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Genfit SA [GNFT]:
Stifel have made an estimate for Genfit SA shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 23, 2020. While these analysts kept the previous recommendation, BofA/Merrill raised their target price to Underperform. The new note on the price target was released on June 25, 2020, representing the official price target for Genfit SA stock. On May 12, 2020, analysts decreased their price target for GNFT shares from 46 to 11.
The Average True Range (ATR) for Genfit SA is set at 0.37
GNFT stock trade performance evaluation
Genfit SA [GNFT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 16.54. With this latest performance, GNFT shares gained by 14.12% in over the last four-week period, additionally plugging by 18.13% over the last 6 months – not to mention a drop of -65.82% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GNFT stock in for the last two-week period is set at 69.72, with the RSI for the last a single of trading hit 77.59, and the three-weeks RSI is set at 64.96 for Genfit SA [GNFT]. The present Moving Average for the last 50 days of trading for this stock 5.24, while it was recorded at 5.40 for the last single week of trading, and 5.92 for the last 200 days.
Genfit SA [GNFT]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Genfit SA [GNFT] shares currently have an operating margin of -215.00. Genfit SA’s Net Margin is presently recorded at -211.24.
Return on Total Capital for GNFT is now -28.94, given the latest momentum, and Return on Invested Capital for the company is -28.92. Return on Equity for this stock declined to -124.08, with Return on Assets sitting at -24.16. When it comes to the capital structure of this company, Genfit SA [GNFT] has a Total Debt to Total Equity ratio set at 218.42. Additionally, GNFT Total Debt to Total Capital is recorded at 68.60, with Total Debt to Total Assets ending up at 59.26. Long-Term Debt to Equity for the company is recorded at 213.03, with the Long-Term Debt to Total Capital now at 66.90.
Reflecting on the efficiency of the workforce at the company, Genfit SA [GNFT] managed to generate an average of -$335,794 per employee. Receivables Turnover for the company is 2.96 with a Total Asset Turnover recorded at a value of 0.11.
Genfit SA [GNFT]: Insider Ownership positions
Positions in Genfit SA stocks held by institutional investors increased at the end of February and at the time of the February reporting period, where 4 institutional holders increased their position in Genfit SA [NASDAQ:GNFT] by around 53,178 shares. Additionally, 4 investors decreased positions by around 133,010 shares, while 6 investors held positions by with 72,703 shares. The mentioned changes placed institutional holdings at 113,485 shares, according to the latest SEC report filing. GNFT stock had 4 new institutional investments in for a total of 53,178 shares, while 3 institutional investors sold positions of 107,314 shares during the same period.